News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SCYNEXIS, Inc. Presents SCY-635 Data on HCV at International Liver Congress



4/25/2013 10:21:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drug discovery and development company SCYNEXIS, Inc. presented 2 studies indicating that oral treatment SCY-635 induces the production of interferon in HCV infected patients at the 48th annual meeting of the European Association for the Study of the Liver.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES